EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients

Putthapoom Lumjiaktase iD, Nanthisa Kemawichanurat iD, Kanthon Santiwiwas, Thatchathum Kuttiyod, Songporn Oranratnachai iD, Narumol Trachu iD, Nanamon Monnamo iD, Khantong Khiewngam, Kantapat Simmalee iD, Thanyanan Reungwetwattana iD

Lung Cancer: Targets and Therapy · 2026-03 · Volume 17 · 1-18

DOI: 10.2147/lctt.s578622 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lung Cancer: Targets and Therapy, 2026-03. Verfasst von Putthapoom Lumjiaktase und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology Laboratory, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

chemotherapyclinical responseimmunological biomarkersnon-targetable advanced NSCLCsurvival outcomes

Autor:innen und Institutionen

  • Clinical Immunology Laboratory, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.
  • Ratchasuda Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.
  • Oncology Unit, Sriphat Medical Center, Faculty of Medicine, Chiangmai University, Chiangmai, Thailand.
  • Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.
  • Division of Medical Oncology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Faculty of Medicine Ramathibodi Hospital, Ramathibodi Lung Cancer Consortium (RLC), Mahidol University, Bangkok, Thailand.

ORCID-Profile: Putthapoom Lumjiaktase, Nanthisa Kemawichanurat, Songporn Oranratnachai, Narumol Trachu, Nanamon Monnamo, Kantapat Simmalee, Thanyanan Reungwetwattana

Zitieren

APA

Lumjiaktase, P., Kemawichanurat, N., Santiwiwas, K., Kuttiyod, T., Oranratnachai, S., Trachu, N., Monnamo, N., Khiewngam, K., Simmalee, K., & Reungwetwattana, T. (2026). Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients. Lung Cancer: Targets and Therapy, Volume 17, 1-18. https://doi.org/10.2147/lctt.s578622

Vancouver

Lumjiaktase P, Kemawichanurat N, Santiwiwas K, Kuttiyod T, Oranratnachai S, Trachu N, et al. Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients. Lung Cancer: Targets and Therapy. 2026;Volume 17:1-18. doi:10.2147/lctt.s578622

BibTeX
@article{Lumjiaktase2026,
  author = {Lumjiaktase, Putthapoom and Kemawichanurat, Nanthisa and Santiwiwas, Kanthon and Kuttiyod, Thatchathum and Oranratnachai, Songporn and Trachu, Narumol and Monnamo, Nanamon and Khiewngam, Khantong and Simmalee, Kantapat and Reungwetwattana, Thanyanan},
  title = {Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients},
  journal = {Lung Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 17},
  pages = {1--18},
  doi = {10.2147/lctt.s578622}
}
Kostenlos starten →